SUNNYVALE, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. announced today that Richard A. Miller, M.D., president and chief executive officer, is scheduled to present a corporate and product update at the JPMorgan Healthcare Conference at 12:30 pm on Thursday, January 15, 2004, in Elizabethan conference room C & D at the Westin St. Francis Hotel, San Francisco, CA.
To access the live audio broadcast or the subsequent archived recording log on to http://www.pharmacyclics.com/ . An archived version of the webcast will be available on the company's website for 30 days.
About Pharmacyclics
Pharmacyclics is a pharmaceutical company developing products to improve upon current therapeutic approaches to cancer and atherosclerosis. The company's products are rationally designed, ring-shaped small molecules called texaphyrins that disrupt the bioenergetic processes of diseased cells, such as cancer and atherosclerotic plaque. More information about the company, its technology, and products can be found on its web site at http://www.pcyc.com/.
Pharmacyclics, Inc.CONTACT: Leiv Lea of Pharmacyclics, Inc., +1-408-774-0330; or Ian R.McConnell of WeissCom Partners, +1-415-362-5018
Web site: http://www.pcyc.com/
